brigitte widemann, md: what is the future beyond mek?
Published 4 years ago • 597 plays • Length 1:01
Download video MP4
Download video MP3
Similar videos
-
12:13
clinical trials for the treatment of nf: past, present and future; brigitte widemann, md
-
32:08
latin american nf conference | mek for pns | brigitte widemann, md, andrea gross, md
-
15:34
interview with brigitte widemann, md about koselugo (selumetinib) the first fda approved drug for nf
-
4:51
tumor talk: living with nf is a process
-
1:00:25
sel-u-bration! children's tumor foundation celebrates the first fda approval for neurofibromatosis
-
15:41
neurofibromatosis - rife frequencies treatment - energy & quantum medicine with bioresonance
-
2:53
nf1 stories - the britzman family
-
3:30
this is nf
-
4:09
teens talk about nf
-
1:24
children's tumor foundation
-
1:05:08
nf1 panel discussion on mpnst biomarkers
-
24:49
ask the expert: nf1 clinical trials, with vanessa merker, phd candidate
-
46:09
nf summit 2022: selumetinib - clinical trial success story
-
5:06
tmm3104: the neurobiology of memory
-
5:29
nf1 with pns: future of treatment with mek inhibitors
-
4:44
koselugo - bchm 4430
-
21:41
clinical trials for the treatment of nf: past, present and future: karin walsh, psyd
-
2:00
jennifer a. belsky, do, pediatric hematology - oncology
-
1:14
todd bierman, md
-
59:36
mek inhibitors and nf1-associated tumors: molecular mechanisms and targeted approaches
-
2:01
frank gertler discusses mena, new cancer test possibilities
-
6:21
neurofibromatosis - type 1 and type 2
Clip.africa.com - Privacy-policy